Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study

OBJECTIVE: To evaluate whether surgery-related complications are increased after hepatic arterial infusion chemotherapy (HAIC) using oxaliplatin plus fluorouracil/leucovorin for conversion compared with primary hepatocellular carcinoma (HCC) resection and the optimal timing of conversion surgery (CS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiongliang, Zheng, Zhikai, Wu, Tianqing, Li, Wenxuan, Wang, Juncheng, Pan, Yangxun, Peng, Wei, Hu, Dandan, Hou, Jiajie, Xu, Li, Zhang, Yaojun, Chen, Minshan, Zhang, Rongxin, Zhou, Zhongguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483136/
https://www.ncbi.nlm.nih.gov/pubmed/36132426
http://dx.doi.org/10.2147/JHC.S379326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483136/
https://www.ncbi.nlm.nih.gov/pubmed/36132426
http://dx.doi.org/10.2147/JHC.S379326

Ejemplares similares